HealthShare NZ Selects Emulex to Monitor Critical Network Traffic

COSTA MESA, Calif.--(BUSINESS WIRE)--

Emulex Corporation ELX, a leader in network connectivity, monitoring and management, today announced that HealthShare NZ a New Zealand-based non-profit shared services provider for healthcare, has selected the EndaceProbe™ Intelligent Network Recorder (INR) and EndaceVision™ Network Visibility Software to monitor its network. HealthShare NZ is jointly owned by five District Health Boards (DHBs) that share a common 10Gb Ethernet (10GbE) IT infrastructure which spans the five DHBs and is managed by the HealthShare NZ central IT group. The HealthShare NZ IT group deployed the Emulex Endace products with the goal of providing quicker and more reliable access to patient medical data, thus improving service to the more than 780,000 patients of the DHBs.

With 77 percent of health expenditure funded by the public through taxes, each DHB needs to provide excellent service with low operational expenditure (OPEX) in order to keep their patient base and funding which, in turn, funds HealthShare NZ. Previously, when HealthShare NZ had encountered network-related issues, post-remediation was slow, as inter-departmental team members had to manually analyze log files by using laptops, WireShark and spanned network ports, to determine the root cause and resolution of the issue. HealthShare NZ needed an easier way to track and trace real world events so that when a customer called, the issue could be resolved quickly. HealthShare NZ selected Emulex to deploy an EndaceProbe INR and EndaceVision, providing powerful visualization capabilities that allow complete and efficient access to the network traffic responsible for network events, while pinpointing root cause quickly.

“As a service provider to five DHBs, we have to quickly discover the cause of IT-related issues that restrict access to patient medical data. The EndaceProbe INR and EndaceVision solution gave us instant return on investment (ROI) when an MRI file could not be accessed. We resolved the issue within 6 minutes where before, this issue could have taken us days to resolve as we combed through thousands of network log files,” said Grant Ardern, chief technology officer, HealthShare NZ. “We now have 100 percent confidence that when the phone rings, we can quickly pinpoint an issue and resolve it since we have all the facts and are not second guessing what the issue could be.”

EndaceVision allows analysts to quickly pinpoint the cause of an issue, while eliminating false positives and eliminates previous inter-departmental conflicts as analysts no longer need to speculate on the cause of an issue. Faster time-to-resolution (TTR) in determining the true root cause ultimately enhanced the management of inter-departmental relationships while allowing for maximum resource utilization across affected IT teams. Ultimately, the Emulex solution allows HealthShare NZ to deliver the service levels required for its five DHBs, with 100 percent traffic capture and a large rotating buffer of long-term storage, providing post remediation support and ensuring that DHBs have access to patient data when they need it.

“HealthShare NZ is a superb example of an organization that requires the utmost in network security and maximum uptime, as patient data is not only highly confidential, it is critically important to have access to it at any time, while ensuring data is safe and uncompromised,” said Ali Hedayati, senior vice president and general manager, Network Visibility Products, Emulex. “The Emulex solution for HealthShare has given them the rapid TTR, complete network performance monitoring and maximized IT resource utilization that is crucial to any company's bottom line, especially a non-profit that relies on public funding to grow its organization. This also benefits HealthShare's patients by helping to ensure that patient data is available when needed.”

Download the HealthShare NZ case study.

Tweet This: HealthShare NZ Selects @Emulex to Monitor Critical Network Traffic http://ow.ly/DOi8C

Follow Emulex on Twitter.

About Emulex

Emulex, a leader in network connectivity, monitoring and management, provides hardware and software solutions for global networks that support enterprise, cloud, government and telecommunications. Emulex's products enable unrivaled end-to-end application visibility, optimization and acceleration. The Company's I/O connectivity offerings, including its line of ultra high-performance Ethernet and Fibre Channel-based connectivity products, have been designed into server and storage solutions from leading OEMs, including Cisco, Dell, EMC, Fujitsu, Hitachi, HP, Huawei, IBM, NetApp and Oracle, and can be found in the data centers of nearly all of the Fortune 1000. Emulex's monitoring and management solutions, including its portfolio of network visibility and recording products, provide organizations with complete network performance management at speeds up to 100Gb Ethernet. Emulex is headquartered in Costa Mesa, Calif., and has offices and research facilities in North America, Asia and Europe. For more information about Emulex ELX please visit http://www.Emulex.com.

“Safe Harbor” Statement

"Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: With the exception of historical information, the statements set forth above contain forward-looking statements that involve risk and uncertainties. We expressly disclaim any obligation or undertaking to release publicly any updates or changes to these forward-looking statements that may be made to reflect any future events or circumstances. We wish to caution readers that actual future results could differ materially from those described in the forward-looking statements as a result of a variety of factors, including those discussed in our filings with the Securities and Exchange Commission, including our recent filings on Forms 10-K and 10-Q, under the caption “Risk Factors.” Those factors and the factors listed below could cause actual results to differ materially from those in the forward-looking statements:

• faster than anticipated declines in the demand for storage networking and fiber channel and slower than expected growth of the converged networking market or the failure of our Original Equipment Manufacturer (OEM) customers to successfully incorporate our products into their systems;
• the highly competitive nature of the markets for our products as well as pricing pressures that may result from such competitive conditions and the emergence of new or stronger competitors as a result of consolidation movements in the market;
• our dependence on a limited number of customers and the effects of the loss of, decrease in or delays of orders by any such customers or the failure of our OEM customers to successfully incorporate our products into their systems;
• our reliance on a limited number of third-party suppliers and subcontractors for components and assembly, many of which are located outside of the United States;
• the effect on our margins of rapid migration of technology and product substitution by customers, including transitions from application specific integrated circuit (ASIC) solutions to boards for selected applications and higher-end to lower-end products, mezzanine card products or modular Local Area Network (LAN) on Motherboard (LOMs);
• the non-linearity and variability in the level of our revenue resulting from the variable and seasonal procurement patterns of our customers;
• the possibility that our goodwill could become impaired in the near term which would result in a non-cash charge and could adversely affect our reported GAAP operating results;
• any inadequacy of our intellectual property protection or our ability to obtain necessary licenses or other intellectual property rights on commercially reasonable terms;
• our ability to attract and retain key technical personnel;
• our ability to respond quickly to technological developments and to benefit from our research and development activities as well as government grants related thereto and delays in product development;
• intellectual property and other litigation against us, with or without merit, that could result in substantial attorneys' fees and costs, cause product shipment delays, loss of patent rights, monetary damages, costs associated with product or component redesigns and require us to indemnify customers or enter into royalty or licensing agreements, which may or may not be available;
• our dependence on sales and product production outside of the United States so that our results could be affected by adverse economic, social, political and infrastructure conditions in those countries;
• that we may fail to realize the anticipated benefits from the acquisition of Endace Limited (Endace) on a timely basis or at all which could result in an impairment of assets or be unable to complete the integration of Endace's technology into our existing operations in a timely and efficient manner;
• the effect of any actual or potential unsolicited offers to acquire us, proxy contests or the activities of activist investors;
• weakness in domestic and worldwide macro-economic conditions, currency exchange rate fluctuations or potential disruptions in world credit and equity markets; terrorist activities, natural disasters, or general economic or political instability and any resulting disruption in our supply chain or customer purchasing patterns; and
• changes in tax rates or legislation, accounting standards and other regulatory changes.

All trademarks, trade names, service marks, and logos referenced herein belong to their respective companies.